Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

shankar besta

  • Home
  • Author: shankar besta

China to dominate propylene capacity additions in Asia by 2030, forecasts GlobalData

China is expected to register the highest propylene capacity additions in Asia, contributing about 70% of the region’s capacity additions by 2030, according to GlobalData, a leading data and analytics company. GlobalData’s latest report, ‘Propylene Capacity and Capital Expenditure Outlook by Region, Countries, Companies, Feedstock, Projects and Forecast to 2030’ reveals that China will dominate […]
Read more

Global missiles and missile defense market to reach $67.9 billion in 2033, says GlobalData

The quest for precision strike missile capabilities and the modernization of air defense systems have emerged as the key factors driving the demand for missiles and missile defense systems (MMDS). The ongoing Russia-Ukraine conflict and the heavy usage of missiles and rockets by both countries have prompted other European countries, such as Poland, Germany, and […]
Read more

Vast majority of healthcare professionals believed that COVID-19 had greatest impact on digital transformation, reveals GlobalData survey

Globally, 71% of healthcare industry professionals expressed that the COVID-19 pandemic had the greatest impact on digital transformation in the healthcare sector during the last few years, among other macro events, according to a survey* by GlobalData, a leading data and analytics company. GlobalData’s latest Thematic Intelligence report, ‘Digital Transformation and Emerging Technologies in the […]
Read more

First-in-class DLL3-targeting BiTE could be the next big player in small-cell lung cancer treatment, says GlobalData

Small cell lung cancer (SCLC), comprising 15% of lung tumors, is a highly aggressive form of malignancy. However, tarlatamab, a bispecific T-cell engager (BiTE) developed by Amgen, recently demonstrated potentially registrational data at the European Society for Medical Oncology (ESMO) 2023 Congress from the Phase II DeLLphi-301 trial.  The drug may become a promising lifeline […]
Read more

Asia to lead global propylene capacity additions by 2030, says GlobalData

Asia is expected to lead the global propylene industry capacity additions with a share of 67% by 2030 by gaining capacity from new-build and expansion projects between 2023 and 2030, according to GlobalData, a leading data and analytics company. GlobalData’s latest report, ‘Propylene Capacity and Capital Expenditure Outlook by Region, Countries, Companies, Feedstock, Projects and […]
Read more

South Korea’s move to build FFX Batch-III frigates aimed at effectively deterring North Korean submarines, says GlobalData

Following the news that Hanwha Ocean signed a $600 million contract with the South Korean state defense procurement agency to build two next-generation frigates; Tushar Mangure, Defense Analyst at GlobalData, a leading data and analytics company, offers his view: “The construction of the next-generation FFX Batch-III frigates is part of South Korea’s naval modernization strategy, […]
Read more

Oil and gas industry overall contract value drops by 26% QoQ during Q3 2023, reveals GlobalData

The oil and gas industry’s overall disclosed contract value witnessed a quarter-on-quarter (QoQ) decrease of 26% in Q3 2023, reveals GlobalData, a leading data and analytics company. GlobalData’s latest report, “Oil and Gas Industry Contracts Analytics by Sector, Region, Planned and Awarded Contracts and Top Contractors, Q3 2023,” reveals that the overall contract value decreased […]
Read more

Japan to continue key military procurement programs despite currency devaluation, says GlobalData

Japan’s currency devaluation has added an extra layer of complexity to its planned defense budget over the coming years. Some fear that this may lead to reduced acquisition budgets and the cancellation or postponement of defense acquisition programs. However, major ongoing procurement programs in Japan, including the Global Combat Air Programme (GCAP), the F-35A/B, Mogami-class […]
Read more

Bristol Myers Squibb’s Opdivo sales to reach $14 billion by 2028, forecasts GlobalData

On 30 October, the European Medicines Agency (EMA) announced that it has validated the application of Bristol Myers Squibb’s Opdivo for the front-line treatment of metastsic urothelial carcinoma in combination with standard-of-care (SOC) cisplatin-based chemotherapy. The news comes on the heels of  Phase lll CheckMate-901 results presented recently at the European Society for Medical Oncology’s […]
Read more

Metaverse faces uphill path ahead as adoption struggles with limited use cases, says GlobalData

The metaverse, a virtual world where users share experiences and interact in real-time within simulated scenarios, will face an uphill path ahead as limited use cases hamper its adoption, says GlobalData, a leading data and analytics company. GlobalData’s latest report, “Metaverse – Thematic Intelligence”, reveals that the metaverse struggles from limited knowledge of the theme, […]
Read more
1 … 95 96 97 98 99 … 136